-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GJ8JsmfGb63fZo9sLQ8yTyRJwqCQXuGN3UxrnnSUaU1gfNe4otn2+1KArf82ItPF bjckcYQhhZkn0kXw2NknNw== 0001179110-08-003166.txt : 20080214 0001179110-08-003166.hdr.sgml : 20080214 20080214093654 ACCESSION NUMBER: 0001179110-08-003166 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071231 FILED AS OF DATE: 20080214 DATE AS OF CHANGE: 20080214 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNTA PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0001157601 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 45 HARTWELL AVE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-274-8200 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gollust Keith R CENTRAL INDEX KEY: 0001325712 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33277 FILM NUMBER: 08608903 BUSINESS ADDRESS: BUSINESS PHONE: 781-274-8200 MAIL ADDRESS: STREET 1: C/O SYNTA PHARMACEUTICALS CORP. STREET 2: 45 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 5 1 edgar.xml FORM 5 - X0202 5 2007-12-31 0 0 1 0001157601 SYNTA PHARMACEUTICALS CORP SNTA 0001325712 Gollust Keith R C/O SYNTA PHARMACEUTICALS CORP. 45 HARTWELL AVENUE LEXINGTON MA 02421 1 0 0 0 Common Stock 2007-08-21 5 G 0 50000 0 D 0 I By Gollust Trust II Common Stock 2007-08-21 5 G 0 50000 0 A 1380970 I By Wyandanch Partners, L.P. Common Stock 39176 D Director Stock Option (Right to Buy) 10.843 2007-12-13 4 D 0 L 28125 0 D 2014-05-27 Common Stock 28125 46875 D Director Stock Option (Right to Buy) 16.00 2007-12-13 4 A 0 L 28125 0 A 2014-05-27 Common Stock 28125 28125 D The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. The Reporting Person has voluntarily amended a common stock option agreement reflecting a May 27, 2004 grant for 75,000 shares at an exercise price of $10.843. The amendment provides that effective as of December 13, 2007, the exercise price for the portion of the option that vests on or after January 1, 2005 - 28,125 shares - has been increased from $10.843 to $16.00. For Section 16(a) purposes, the Reporting Person is reporting this amendment as a cancellation of the affected portion of the original option and the grant of a replacement option. The Reporting Person received no consideration in connection with this amendment. The option vested as to 50% of the shares on May 27, 2004 and as to an additional 6.25% of the shares on the last day of each successive three-month period thereafter and is currently fully vested. /s/ Ann Margaret Eames, Attorney-in-Fact 2008-02-14 -----END PRIVACY-ENHANCED MESSAGE-----